Shares of Moderna Inc. MRNA rallied 3.35% to $151.93 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.07% to 13,626.06 and Dow Jones Industrial Average DJIA falling 0.07% to 30,937.04. This was the stock's second consecutive day of gains. Moderna Inc. closed $26.57 short of its 52-week high ($178.50), which the company reached on December 1st.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV fell 1.54% to $108.80, Amgen Inc. AMGN rose 0.58% to $258.60, and AstraZeneca PLC ADR AZN rose 0.80% to $54.44. Trading volume (16.7 M) remained 10.6 million below its 50-day average volume of 27.3 M.